Nov 21 (Reuters) - Oxford Immunotec Global Plc :Oxford Immunotec Global Plc - on Nov 17, unit entered into a second amendment to purchase agreement with Mabtech AB.Oxford Immunotec Global says second amendment extends term of agreement until December 31, 2023 & establishes pricing - SEC Filing.
Nov 21 (Reuters) - Hamilton Thorne Ltd :Hamilton Thorne announces 147% revenue growth for the quarter ended September 30, 2017.Hamilton Thorne Ltd - qtrly earnings per share $0.01.Hamilton Thorne Ltd - qtrly sales $6.1 million versus $2.4 million.
Nov 21 (Reuters) - ORTIVUS AB :Q3 NET SALES AT SEK 11.8 MILLION VERSUS SEK 21.7 MILLION YEAR AGO .Q3 EBITDA LOSS AT SEK 1.1 MILLION VERSUS PROFIT SEK 7.2 MILLION YEAR AGO.
Nov 20 (Reuters) - Agilent Technologies Inc ::Agilent Technologies reports fourth-quarter fiscal year 2017 financial results.Sees FY 2018 non-gaap earnings per share $2.50 to $2.56.Sees Q1 2018 non-gaap earnings per share $0.55 to $0.57.Q4 gaap earnings per share $0.54.Sees FY 2018 revenue $4.72 billion to $4.74 billion.Sees Q1 2018 revenue $1.145 billion to $1.165 billion.Q4 revenue $1.19 billion versus I/B/E/S view $1.17 billion.Q4 earnings per share view $0.62 -- Thomson Reuters I/B/E/S.Q4 non-gaap earnings per share $0.67.Q4 earnings per share view $0.62, revenue view $1.17 billion -- Thomson Reuters I/B/E/S.FY 2018 earnings per share view $2.59, revenue view $4.73 billion -- Thomson Reuters I/B/E/S.FY 2018 earnings per share view $2.59, revenue view $4.73 billion -- Thomson Reuters I/B/E/S.
Nov 20 (Reuters) - Axogen Inc :Axogen Inc - management reiterates 2017 annual revenue will grow at least 40 pct over 2016 revenue and gross margins will remain above 80 pct.Axogen Inc - management expects that 2018 revenue will grow at least 40 pct over 2017 revenue and gross margins will remain above 80 pct.
Nov 20 (Reuters) - Microport Scientific Corp <0853.HK>:LivaNova - If deal to sell co's cardiac rhythm management business to Microport Cardiac Rhythm terminated, breaching party to pay termination fee of $6 million.
Nov 20 (Reuters) - Microport Scientific Corp <0853.HK>::Announces acquisition of CRM business from Livanova PLC.Unit buys CRM business for initial consideration of US$190 million from Livanova PLC.
Nov 20 (Reuters) - THERACLION SA :ANNOUNCES THE PRESENTATION OF DATA FROM THE U.S. PILOT TRIAL OF ECHOTHERAPY WITH ECHOPULSE®.RESULTS SUGGEST POSITIVE OUTCOME OF ONGOING PIVOTAL TRIAL OF ECHOPULSE® FOR NON-INVASIVE TREATMENT OF BREAST FIBROADENOMAS.OVER 25% OF PATIENTS HAVE ALREADY BEEN TREATED IN THIS PIVOTAL TRIAL.TRIAL WILL ENROLL APPROXIMATELY 100 PATIENTS AT FOUR CENTERS IN U.S..
Nov 17 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies provides clarification on clinical trial results and confirms intention to include traumatic brain injury (TBI) registrational and long-term treatment trial data to support application for clearance by the FDA.
Nov 17 (Reuters) - Guangdong Biolight Meditech Co Ltd <300246.SZ> ::Says it completed establishment of wholly owned subsidiary in Germany, named as BIOLIGHT HEALTHCARE GmbH.